Lexeo Therapeutics (LXEO) Capital Expenditures (2022 - 2026)
Lexeo Therapeutics recorded quarterly Capital Expenditures of $35000.0 in Q1 2026, down 87.89% quarter-over-quarter from $289000.0 in Q3 2025.
Lexeo Therapeutics' Capital Expenditures history runs 5 years deep, the most recent figure standing at $35000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $35000.0; the TTM figure through Mar 2026 stood at $792000.0 (changed N/A YoY), while the FY2025 annual figure was $397000.0, down 17.46% from the prior year.
- Capital Expenditures came in at $35000.0 for Q1 2026 at Lexeo Therapeutics, down from $289000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $468000.0 in Q4 2024 to a low of -$172000.0 in Q2 2024.
- A 5-year average of $114300.0 and a median of $57500.0 in 2023 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 1441.67% in 2024 and fell as far as 509.52% in 2024.
- Lexeo Therapeutics' Capital Expenditures stood at $223000.0 in 2022, then tumbled by 67.26% to $73000.0 in 2023, then surged by 541.1% to $468000.0 in 2024, then slumped by 38.25% to $289000.0 in 2025, then slumped by 87.89% to $35000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $35000.0, $289000.0, and $468000.0 for Q1 2026, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Sep 30, 2025 | 289,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Jun 30, 2024 | -172,000.00 |
| Jun 30, 2024 | -172,000.00 |
| Mar 31, 2024 | 185,000.00 |
| Mar 31, 2024 | 185,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Dec 31, 2022 | 223,000.00 |